Principal Financial Group Inc. Sells 12,781 Shares of agilon health, inc. (NYSE:AGL)

Principal Financial Group Inc. lowered its stake in shares of agilon health, inc. (NYSE:AGL) by 30.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 28,894 shares of the company’s stock after selling 12,781 shares during the quarter. Principal Financial Group Inc.’s holdings in agilon health were worth $114,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Arizona State Retirement System increased its stake in shares of agilon health by 2.5% in the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after buying an additional 2,070 shares during the period. J.Safra Asset Management Corp increased its holdings in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the last quarter. CWM LLC lifted its stake in agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after buying an additional 7,288 shares during the period. Signaturefd LLC increased its stake in shares of agilon health by 166.2% in the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock valued at $77,000 after acquiring an additional 7,398 shares during the last quarter. Finally, Wedbush Securities Inc. grew its holdings in shares of agilon health by 72.6% in the 2nd quarter. Wedbush Securities Inc. now owns 20,710 shares of the company’s stock valued at $135,000 after buying an additional 8,710 shares during the period.

Analyst Upgrades and Downgrades

AGL has been the subject of a number of recent research reports. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Stifel Nicolaus reduced their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research report on Tuesday, November 12th. Barclays lowered their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Finally, Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a report on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $6.05.

agilon health Trading Down 9.3 %

Shares of agilon health stock opened at $2.05 on Wednesday. The business has a 50-day moving average price of $2.86 and a 200-day moving average price of $4.72. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $13.76. The firm has a market cap of $844.64 million, a price-to-earnings ratio of -2.18 and a beta of 0.60. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period last year, the business posted ($0.06) earnings per share. Equities research analysts anticipate that agilon health, inc. will post -0.47 EPS for the current fiscal year.

Insider Transactions at agilon health

In related news, CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 3.20% of the company’s stock.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.